Recurrent Hematologic Malignancy

Explore clinical trials studying Recurrent Hematologic Malignancy. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Hematologic Malignancy trial results

Recruiting

NCT04515810

Conditions: Death, Hematologic Diseases, Hematologic Neoplasms, +11 more
Locations: Northwell Health Manhasset, New York, United States

Mount Sinai Hospital New York, United States

NYP/Weill Cornell Medical Center New York, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

Completed

NCT04681105

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
Locations: City of Hope Medical Center Duarte, California, United States

Completed

NCT05058339

Conditions: Advanced Malignant Solid Neoplasm, COVID-19, COVID-19 Infection, +25 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Completed

NCT01822509

Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blood Protein Disorders, Bone Marrow Diseases, +44 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

City of Hope South Pasadena South Pasadena, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

View all 13 locations

Completed

NCT02805075

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States